Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process

Over the past two decades, the development of targeted immunotherapeutics for relapsing-remitting multiple sclerosis has been successfully orchestrated through the efficacious modulation of neuroinflammatory outcomes demonstrated in the experimental autoimmune encephalomyelitis (EAE) model. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Damianidou, Olympia, Theotokis, Paschalis, Grigoriadis, Nikolaos, Petratos, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692119/
https://www.ncbi.nlm.nih.gov/pubmed/34975310
http://dx.doi.org/10.7150/ijms.66350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692119/
https://www.ncbi.nlm.nih.gov/pubmed/34975310
http://dx.doi.org/10.7150/ijms.66350

Ejemplares similares